Cargando…
Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia
This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recomm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227723/ https://www.ncbi.nlm.nih.gov/pubmed/31652090 http://dx.doi.org/10.1080/21645515.2019.1667206 |
_version_ | 1783534547738034176 |
---|---|
author | Khoo, Yvonne S. K. Ghani, A. Ab Navamukundan, A. A. Jahis, R. Gamil, A. |
author_facet | Khoo, Yvonne S. K. Ghani, A. Ab Navamukundan, A. A. Jahis, R. Gamil, A. |
author_sort | Khoo, Yvonne S. K. |
collection | PubMed |
description | This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recommendations on new vaccines, outline the different steps in decision-making on incorporating a new vaccine into the National Immunization Program, describe its issues and challenges, and explore the commercial viability and challenges of producing local permissible (halal) vaccines. Through this review, we hope readers understand that alternatives are present to replace ingredients of concern in vaccines. Halal certification and introduction of a new vaccine into a program are strictly conducted and health-care providers must be prepared to educate the public on this. At the same time, it is hoped that the production of halal vaccine in Malaysia will promote self-reliance in Muslim-populated countries. |
format | Online Article Text |
id | pubmed-7227723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-72277232020-05-20 Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia Khoo, Yvonne S. K. Ghani, A. Ab Navamukundan, A. A. Jahis, R. Gamil, A. Hum Vaccin Immunother Review This review aims to present the unique considerations for manufacturing and the regulation of new vaccines in Muslim-populated countries such as Malaysia. Our specific objectives are to highlight vaccine production and the ingredients of concern, summarize the current mechanism for ruling and recommendations on new vaccines, outline the different steps in decision-making on incorporating a new vaccine into the National Immunization Program, describe its issues and challenges, and explore the commercial viability and challenges of producing local permissible (halal) vaccines. Through this review, we hope readers understand that alternatives are present to replace ingredients of concern in vaccines. Halal certification and introduction of a new vaccine into a program are strictly conducted and health-care providers must be prepared to educate the public on this. At the same time, it is hoped that the production of halal vaccine in Malaysia will promote self-reliance in Muslim-populated countries. Taylor & Francis 2019-10-25 /pmc/articles/PMC7227723/ /pubmed/31652090 http://dx.doi.org/10.1080/21645515.2019.1667206 Text en © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Review Khoo, Yvonne S. K. Ghani, A. Ab Navamukundan, A. A. Jahis, R. Gamil, A. Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title | Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title_full | Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title_fullStr | Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title_full_unstemmed | Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title_short | Unique product quality considerations in vaccine development, registration and new program implementation in Malaysia |
title_sort | unique product quality considerations in vaccine development, registration and new program implementation in malaysia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227723/ https://www.ncbi.nlm.nih.gov/pubmed/31652090 http://dx.doi.org/10.1080/21645515.2019.1667206 |
work_keys_str_mv | AT khooyvonnesk uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia AT ghaniaab uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia AT navamukundanaa uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia AT jahisr uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia AT gamila uniqueproductqualityconsiderationsinvaccinedevelopmentregistrationandnewprogramimplementationinmalaysia |